Adaptive Radiotherapy: Principles, Technologies, Clinical Applications, and Future Directions — A Comprehensive Review
Abstract
Background: Adaptive radiotherapy (ART) represents a paradigm shift in radiation oncology, enabling real-time or iterative modification of treatment plans in response to anatomical, physiological, and biological changes occurring throughout the course of treatment. Unlike conventional radiotherapy, which relies on a single pre-treatment plan, ART dynamically adjusts beam delivery to account for inter-and intrafraction variations in tumor volume, shape, and position, as well as changes in surrounding normal tissues and organs at risk (OARs) . Methods: A comprehensive literature search was performed across PubMed, MEDLINE, Embase, and the Cochrane Library from January 2000 to December 2024, using the MeSH terms 'adaptive radiotherapy,''online adaptation,''offline adaptation,''image-guided radiotherapy,''MR-linac,' and 'cone-beam CT.' A total of 148 peer-reviewed articles, systematic reviews, meta-analyses, and clinical guidelines were screened; 102 met the inclusion criteria and are cited herein. Results: Evidence from randomized and observational studies demonstrates that ART reduces radiation dose to OARs by 10–35% compared with conventional radiotherapy while maintaining equivalent or superior tumor control rates. Emerging magnetic resonance-guided linac (MR-linac) technologies and artificial intelligence (AI)-driven automated re-planning systems have substantially reduced online adaptation workflow times to under 30 minutes, enabling clinical scalability. Conclusion: ART is rapidly becoming the standard of care for anatomically complex and motion-sensitive malignancies including head and neck, prostate, cervical, and lung cancers. Continued innovation in imaging, automation, and biological adaptation promises to further enhance therapeutic ratios and patient outcomes.